Search by Drug Name or NDC
NDC 45802-0717-08 Terconazole 80 mg/1 Details
Terconazole 80 mg/1
Terconazole is a VAGINAL SUPPOSITORY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is TERCONAZOLE.
MedlinePlus Drug Summary
Terconazole is used to treat fungal and yeast infections of the vagina. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 45802-0717-08Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Terconazole Vaginal Cream, Vaginal Suppositories
Product Information
| NDC | 45802-0717 |
|---|---|
| Product ID | 45802-717_e873e5f0-ffa5-4827-b79b-b9973d6ad0d6 |
| Associated GPIs | 55104070005210 |
| GCN Sequence Number | 007009 |
| GCN Sequence Number Description | terconazole SUPP.VAG 80 MG VAGINAL |
| HIC3 | Q4F |
| HIC3 Description | VAGINAL ANTIFUNGALS |
| GCN | 48370 |
| HICL Sequence Number | 003033 |
| HICL Sequence Number Description | TERCONAZOLE |
| Brand/Generic | Generic |
| Proprietary Name | Terconazole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Terconazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUPPOSITORY |
| Route | VAGINAL |
| Active Ingredient Strength | 80 |
| Active Ingredient Units | mg/1 |
| Substance Name | TERCONAZOLE |
| Labeler Name | Padagis Israel Pharmaceuticals Ltd |
| Pharmaceutical Class | Azole Antifungal [EPC], Azoles [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077149 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 45802-0717-08 (45802071708)
| NDC Package Code | 45802-717-08 |
|---|---|
| Billing NDC | 45802071708 |
| Package | 3 BLISTER PACK in 1 CARTON (45802-717-08) / 1 SUPPOSITORY in 1 BLISTER PACK (45802-717-00) |
| Marketing Start Date | 2006-08-28 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 24.0633 |
| Pricing Unit | EA |
| Effective Date | 2024-01-17 |
| NDC Description | TERCONAZOLE 80 MG SUPPOSITORY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis